Wednesday, 25 Apr 2018


Datesort ascending Type Title Save
06 Sep 2017 News Psoriasis Doubles Mortality Risk
06 Sep 2017 Social Psoriasis pruritus seen in >80%; metaanalysis 13 trials shows Anti Il-17, JAK inhib, ADA, apremilast reduce pruritus
06 Sep 2017 Social Minimal Dz Activity in PsA (SJC/TJC<1, PASI<1, HAQ<0.5) achieved in 45-49% @6 mos Rx w/ infliximab or golimumab IV
28 Aug 2017 Social See what Drs. Mease, Gibofsky, Cush have to say about FDA hearing on Tofacitinib for Psoriatic Arthritis
23 Aug 2017 News IV Golimumab Shines in Psoriatic Arthritis
22 Aug 2017 News Therapeutic Update: 5 Questions on FDA Hearing for Tofacitinib in PsA
14 Aug 2017 News Psoriatic Arthritis Patients with Comorbidities have Worse Disease and Poor Responses
04 Aug 2017 News FDA Arthritis Advisory Panel Endorses Tofacitinib Approval for Psoriatic Arthritis
03 Aug 2017 Social FDA Arthritis Advisory Panel votes 10-1 in favor of approving tofacitinib (Xeljanz) for use in Psoriatic athritis. FDA decision pending.
03 Aug 2017 News Pediatric Consensus on Comorbidity Assessments
27 Jul 2017 Social EU/EMA follows FDA decision to approve Orencia (abatacept) for use in active psoriatic arthritis as mono or combo Rx
24 Jul 2017 Social Dr Phil Helliwell presents a 27 yr old woman w/ polyarthritis, enthesitis, PsA but no evidence of psoriasis.
20 Jul 2017 News Obesity Impairs TNF Inhibitor Responses in Axial Spondyloarthritis
18 Jul 2017 Social 320 pt Rheum-Derm clinic in Vancouver - lupus is most common rheum dx; dermatitis & psoriasis most common Derm Dx
17 Jul 2017 News FDA Approves Tremfya (guselkumab) for Plaque Psoriasis
14 Jul 2017 News Statins Improve Survival in Ankylosing Spondylitis
10 Jul 2017 News Orencia Approved for Use in Psoriatic Arthritis
23 Jun 2017 News IV Golimumab in Psoriatic Arthritis
21 Jun 2017 News Tildrakizumab, an IL-23 Inhibitor, is Successful in Plaque Psoriasis
01 Jun 2017 Social 33 pts w/ Axial Spondyloarthritis Rx w/ NSAIDs decreased their MRI sacroiliitis and BM edema w/ longterm NSAIDs only